Spinosad Topical
ApprovedRecruiting 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Scabies
Conditions
Scabies
Trial Timeline
Mar 4, 2022 → Mar 31, 2026
NCT ID
NCT05310734About Spinosad Topical
Spinosad Topical is a approved stage product being developed by Inotiv for Scabies. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05310734. Target conditions include Scabies.
What happened to similar drugs?
0 of 2 similar drugs in Scabies were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
20
Activity
15
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05310734 | Approved | Recruiting |
Competing Products
3 competing products in Scabies
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Permethrin | Dr. Reddy's Laboratories | Phase 3 | 37 |
| Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam | Viatris | Phase 2 | 32 |
| Permethrin Cream, 5% + Elimite | Mayne Pharma Group | Phase 3 | 30 |